The 88 rating InvestorsObserver gives to Viridian Therapeutics Inc (VRDN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, VRDN’s 88 overall rating means the stock scores better than 88 percent of all stocks.
VRDN has an Overall Score of 88. Find out what this means to you and get the rest of the rankings on VRDN!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 88 means the stock is more attractive than 88 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Viridian Therapeutics Inc Stock Today?
Viridian Therapeutics Inc (VRDN) stock is trading at $22.82 as of 1:47 PM on Monday, Sep 12, a gain of $0.15, or 0.66% from the previous closing price of $22.67. The stock has traded between $21.75 and $23.88 so far today. Volume today is low. So far 303,638 shares have traded compared to average volume of 1,225,825 shares.
Click Here to get the full Stock Report for Viridian Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
